Structures by: Silva M. R.
Total: 26
Hexa(2,4-nonanedionate)(2,2'-bipyrimidine)di-erbium(III)
C31H48ErN2O6
New J. Chem. (2016) 40, 10 8251
a=16.7455(6)Å b=13.1161(4)Å c=16.7312(6)Å
α=90.00° β=110.758(2)° γ=90.00°
Metropolol
C15H25NO3
CrystEngComm (2019) 21, 29 4319
a=16.54(2)Å b=5.411(7)Å c=17.90(2)Å
α=90.00° β=100.47(2)° γ=90.00°
2-hydroxy-N-isopropyl-3-(4-(2-methoxyethyl)phenoxy)propan-1-aminium nicotinate
C21H30N2O5
CrystEngComm (2019) 21, 29 4319
a=8.1740(17)Å b=9.264(2)Å c=14.884(3)Å
α=98.244(5)° β=96.622(4)° γ=99.623(5)°
4-(p-anisidino)-8-tosylimino pyrimido[5,4-d]pyrimidina-2-one
C20H18N6O4S,C2H4O2,H2O
Journal of the Chemical Society, Perkin Transactions 1 (2001) 10 1241
a=5.063(4)Å b=29.246(6)Å c=16.325(2)Å
α=90.00° β=95.98(3)° γ=90.00°
C18H16N2O2
C18H16N2O2
RSC Adv. (2015)
a=12.0978(3)Å b=3.97900(10)Å c=15.5788(4)Å
α=90° β=100.0550(10)° γ=90°
Potassium bis-quinato tungstate hydrate
C14H29K2O18.5W
Journal of the Chemical Society, Dalton Transactions (2002) 10 2126
a=16.8239(13)Å b=17.772(2)Å c=8.217(4)Å
α=90.00° β=90.00° γ=90.00°
Tris(1,1,1,5,5,6,6,7,7,7-decafluoro-2,4-heptanedionate)mono(5-nitro-1,10-phenanthroline) ytterbium(III)
C33H10F30N3O8Yb
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13516-13526
a=10.0391(3)Å b=25.3149(7)Å c=18.4810(5)Å
α=90.00° β=117.213(2)° γ=90.00°
Tris(1,1,1-trifluoro-2,4-pentanedionate)mono(5-nitro-1,10-phenanthroline)ytterbium(III)
C27H19F9N3O8Yb
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13516-13526
a=9.7806(16)Å b=14.750(2)Å c=23.952(3)Å
α=90.00° β=114.101(5)° γ=90.00°
Tris(1,1,1-trifluoro-5,5-dimethyl-2,4-hexanedionate)mono(5-nitro-1,10-phenanthroline) ytterbium(III)
C36H37F9N3O8Yb
Dalton transactions (Cambridge, England : 2003) (2013) 42, 37 13516-13526
a=9.9036(3)Å b=22.3251(7)Å c=39.8599(11)Å
α=90.00° β=90.782(2)° γ=90.00°
Tris(2,4-hexanedionate) mono(5-nitro-1,10-phenanthroline)erbium(III)
C30H34ErN3O8
Dalton transactions (Cambridge, England : 2003) (2014) 43, 18 6752-6761
a=9.8653(4)Å b=34.3089(13)Å c=9.4512(3)Å
α=90.00° β=103.128(2)° γ=90.00°
Tris(2,4-hexanedionate) mono(2,2-bipyridine)erbium(III)
C28H35ErN2O6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 18 6752-6761
a=9.4068(2)Å b=23.0764(4)Å c=13.1493(3)Å
α=90.00° β=92.5718(12)° γ=90.00°
Tris(2,4-hexanedionate) mono(bathophenanthroline)erbium(III)
C42H43ErN2O6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 18 6752-6761
a=11.9780(7)Å b=12.4180(7)Å c=13.9870(8)Å
α=102.863(3)° β=94.026(3)° γ=107.715(3)°
Trans-1,4-cyclohexanedimethanol
C8H16O2
CrystEngComm (2014) 16, 48 10977
a=10.6792(15)Å b=9.1741(14)Å c=9.0549(12)Å
α=90.00° β=100.211(3)° γ=90.00°
Trans-1,4-cyclohexanedimethanol
C8H16O2
CrystEngComm (2014) 16, 48 10977
a=5.1064(4)Å b=5.1749(4)Å c=16.3054(10)Å
α=88.250(5)° β=81.485(5)° γ=79.662(5)°
Picolinamide
C6H6N2O
CrystEngComm (2012) 14, 24 8649
a=5.3463(2)Å b=11.3075(5)Å c=19.9400(10)Å
α=90.00° β=98.087(3)° γ=90.00°
Α - picolinamide
C6H6N2O
CrystEngComm (2012) 14, 24 8649
a=5.1973(3)Å b=7.0850(4)Å c=16.4114(10)Å
α=90.00° β=101.233(4)° γ=90.00°
Picolinamide
C6H6N2O
CrystEngComm (2012) 14, 24 8649
a=5.2831(4)Å b=11.2901(9)Å c=19.8654(17)Å
α=90.00° β=98.2809(17)° γ=90.00°
Α - picolinamide
C6H6N2O
CrystEngComm (2012) 14, 24 8649
a=5.1578(4)Å b=7.0249(5)Å c=16.2192(11)Å
α=90.00° β=100.728(5)° γ=90.00°
Tris(1,1,1-trifluoro-2,4-pentanedionate)mono(5-nitro-1,10-phenanthroline)erbium(III)
C27H19ErF9N3O8
Dalton transactions (Cambridge, England : 2003) (2014) 43, 48 18087-18096
a=9.7956(9)Å b=14.8137(15)Å c=24.0161(18)Å
α=90.00° β=114.072(3)° γ=90.00°
Tris(1,1,1-trifluoro-2,4-pentanedionate)mono(2,2'-bipyridine)erbium(III)
C25H20ErF9N2O6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 48 18087-18096
a=22.705(5)Å b=9.2115(18)Å c=15.646(3)Å
α=90.00° β=118.042(3)° γ=90.00°
Tris(1,1,1-trifluoro-2,4-pentanedionate)mono(bathophenanthroline)erbium(III)
C39H28ErF9N2O6
Dalton transactions (Cambridge, England : 2003) (2014) 43, 48 18087-18096
a=17.2382(4)Å b=16.2042(3)Å c=14.0954(3)Å
α=90.00° β=102.4740(10)° γ=90.00°
Tris(4,4,4-trifluoro-1-(2-furyl)-1,3-butanedionate) mono(2,2-bipyridine)erbium(III)
C34H20ErF9N2O9
Dalton transactions (Cambridge, England : 2003) (2015) 44, 3 1264-1272
a=10.124(3)Å b=16.991(6)Å c=21.418(7)Å
α=90.00° β=104.820(7)° γ=90.00°
<i>catena</i>-Poly[[(1,10-phenanthroline-κ^2^<i>N</i>,<i>N</i>)copper(II)]-μ-2,2'-iminodibenzoato-κ^4^<i>O</i>,<i>O</i>':<i>O</i>'',<i>O</i>''']
C26H17CuN3O4
Acta Crystallographica Section E (2013) 69, 5 m255-m256
a=31.7536(6)Å b=9.8492(2)Å c=14.4865(3)Å
α=90.00° β=113.2220(10)° γ=90.00°
1-[(<i>E</i>)-Anthracen-9-ylmethylidene]-2-(2,4-dinitrophenyl)hydrazine
C21H14N4O4
Acta Crystallographica Section E (2013) 69, 5 o705
a=5.6355(4)Å b=8.1597(5)Å c=36.794(2)Å
α=90.00° β=90.00° γ=90.00°
RS-atenolol
C14H22N2O3
Crystal Growth & Design (2007) 7, 3 496
a=55.83(3)Å b=5.559(3)Å c=9.734(2)Å
α=90.00° β=100.042(6)° γ=90.00°
S-atenolol
2(C14H22N2O3)
Crystal Growth & Design (2007) 7, 3 496
a=54.43(3)Å b=5.712(3)Å c=9.676(2)Å
α=90.00° β=99.510(6)° γ=90.00°